Viewing Study NCT00176293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-06-14 @ 12:50 PM
Study NCT ID: NCT00176293
Status: TERMINATED
Last Update Posted: 2015-04-21
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
Sponsor: University of Kentucky
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate View
None prostate cancer View
None doxil View
None dexamethasone View
None metastatic View
None hormone refractory View